Charles River Laboratories International, Inc. $CRL Shares Acquired by State of Wyoming

The State of Wyoming grew its position in Charles River Laboratories International, Inc. by 16.5% during the first quarter. Official reports show the state acquired 208 additional shares, bringing its total holdings to 1,468 shares in the medical research company.

Key Takeaways:

  • The State of Wyoming increased its stake in Charles River Laboratories International by 16.5%.
  • Total holdings for the state are now at 1,468 shares.
  • The state acquired an additional 208 shares in the first quarter.
  • These developments come from official Holdings Channel reports.
  • Zolmax published the story on 2025-09-04.

Introduction

Charles River Laboratories International, Inc. (NYSE: CRL) has drawn increased attention from the State of Wyoming. Recent public filings indicate that during the first quarter, Wyoming expanded its position in the medical research company by 16.5%.

Focus on the First Quarter

The timing of Wyoming’s move is significant: it occurred within the first quarter, reflecting a proactive approach to adjusting its investment portfolio. According to Holdings Channel, the state took clear steps to bolster its position in CRL, citing both the company’s potential and its established presence in medical research.

Adding 208 Shares

Wyoming’s holdings grew to 1,468 shares in total during the period. This represents an addition of 208 shares, which underscores the state’s increasing confidence in Charles River Laboratories International. While the exact rationale behind the expanded holdings isn’t detailed in the filings, the acquisition highlights Wyoming’s decision to allocate more capital toward this sector.

Implications for Investment

Charles River Laboratories International’s focus on medical research places it under consistent market scrutiny. Any adjustments in share ownership, such as Wyoming’s recent purchase, can be indicative of broader trends or investor sentiment. However, specific details on how these holdings may influence future performance remain speculative.

Conclusion

With a consistent track record in the medical research field, Charles River Laboratories International continues to capture the attention of institutional investors. Wyoming’s 16.5% increase, as reported by Holdings Channel, highlights ongoing confidence in the company’s direction and potential.

More from World

Off-Script Drama in Louisiana Senate Race
by The Advocate
19 hours ago
1 min read
Stephanie Grace: Could the Republican Senate race be veering off script?
Hungry for Payback: Nurmagomedov vs. Dvalishvili
by Bloody Elbow
22 hours ago
1 min read
Umar Nurmagomedov favors revenge against Merab Dvalishvili over the UFC bantamweight title
Health Programs at Risk Amid Funding Delays
by Times Of San Diego
22 hours ago
2 mins read
The Trump administration is holding up billions in HHS funding
Lake Mead Faces Historic Decline by 2027
by Arizona Daily Sun
22 hours ago
2 mins read
Lake Mead’s slow demise just sped up in latest federal study
Racing to Glory: 2026 Race to Alaska Leaders
by Ketchikan Daily News
1 day ago
1 min read
2026 Race to Alaska
Library Powers Petition Spurs Borough Debate
by Ketchikan Daily News
1 day ago
1 min read
Library powers mentioned in petition
Springfield Man Sentenced to 13 Years Prison
by Pantagraph
1 day ago
1 min read
Springfield man gets 13 years for burglary, armed robbery cases
District 1 Candidates Tackle Aspen’s Key Issues
by Aspen Times
1 day ago
1 min read
BOCC District 1 candidates discuss key Aspen issues
Tied and Masked: Wyoming Boys’ School Lawsuit
by Daily Express Us
1 day ago
1 min read
Students at ‘evil’ school were tied to chairs for ‘8 hours a day with masks over heads’
Rethinking Sexuality: Lessons from the Animal World
by Rolling Stone
1 day ago
2 mins read
We’ve Been Thinking About Animal Sexuality All Wrong
Green Bay Drones Revolutionize Emergency Response
by Press Times
1 day ago
2 mins read
GBPD, GBMFD launch Drone as First Responder program
When a Celebrity Feud Wrecks a Brand
by Fast Company
1 day ago
3 mins read
Blake Lively and Justin Baldoni’s feud ruined a $100 million brand. It’s a crucial lesson for every founder